Events Search and Views Navigation
April 2016
June 2016
BIO 2016
“Curative Therapies: Aligning Policy with Science to Ensure Patient Access” (Mark Trusheim).
Find out more »DIA 52nd Annual Meeting
(Gigi Hirsch & Hans-Georg Eichler – Session Co-Chairs).
Find out more »DIA 52nd Annual Meeting
“Europe and the US: Making Outcomes-Based Health Care Possible.” Details here. (Gigi Hirsch).
Find out more »September 2016
NBER Pre-Conference on Economic Dimensions of Personalized and Precision Medicine
NBER Pre-Conference on Economic Dimensions of Personalized and Precision Medicine
Find out more »October 2016
2016 Cell & Gene Meeting on the Mesa
“The Impact of a New Healthcare Model: What Do Payers Think of Gene Therapies?” (Mark Trusheim)
Find out more »November 2016
Address by Gerald J. Dal Pan, MD, MHS
The FDA’s Director of the Office of Surveillance and Epidemiology in FDA’s Center for Drug Evaluation and Research will deliver the address, “Assessing the Impact of Postmarketing Regulatory Programs and Actions.” Please note that participation is by invitation only.
Find out more »December 2016
The Drug Development Paradigm in Oncology
hosted by the National Cancer Policy Forum. (G.K. Raju)
Find out more »January 2017
DIA Integrated Adaptive Development and Decision Making Conference
(Gigi Hirsch) Panel: Adaptive Biomedical Innovations: The Way Forward (Stella Blackburn, Moderator)
Find out more »April 2017
Cell & Gene Therapy Investor Day
(Mark Trusheim) Panel: Gene Therapy: Commercialization Readiness & Market Access Challenges
Find out more »